Pfizer and Moderna set to adapt to Omicron COVID variant
The manufacturers of America’s most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential ...
The manufacturers of America’s most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential ...
The US government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment ...
Ten of New York’s mass-vaccination sites will now jab kids aged 5 to 11 with the COVID vaccine, Gov. ...
Sign up for our special edition newsletter to get a daily update on the coronavirus pandemic. Medical giant Pfizer ...
Pharmaceutical giant Pfizer announced Friday that its antiviral COVID-19 pill, when administered in conjunction with a widely used HIV ...
Moderna on Thursday slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to ...
Pfizer is hiking sales expectations for its top-selling COVID-19 vaccine again, and its early look at 2022 also falls ...
Sign up for our special edition newsletter to get a daily update on the coronavirus pandemic. WASHINGTON — The ...
NAIROBI, Kenya — African health officials and the United Nations are warning of a looming shortage of more than ...
Food and Drug Administration researchers found the Pfizer-BioNTech vaccine to be highly effective at protecting kids from COVID-19 – ...
Get the latest news from the US and around the world in your inbox.
SUBSCRIBE
Welcome to the world’s premier daily news platform. We bring you the latest news from the US and around the world right at your fingertips.